Urolithin A ameliorates obesity-induced metabolic cardiomyopathy in mice via mitophagy activation

• Published in: Acta pharmacologica Sinica 2023-02, Vol.44 (2), p.321-331
• Main Authors: Huang, Jian-rong, Zhang, Ming-hua, Chen, Ying-jie, Sun, Yu-ling, Gao, Zhi-min, Li, Zhuo-jia, Zhang, Gui-ping, Qin, Yuan, Dai, Xiao-yan, Yu, Xi-yong, Wu, Xiao-qian
• Format: Article
• Language: English
• Subjects: Animals; Autophagy; Biomedical and Life Sciences; Biomedicine; Cardiomyocytes; Cardiomyopathies - metabolism; Cardiomyopathy; Fatty acids; High fat diet; Immunology; Internal Medicine; Medical Microbiology; Metabolic rate; Metabolism; Metabolites; Mice; Mice, Obese; Microflora; Mitochondria; Mitophagy; Myocytes, Cardiac - metabolism; Obesity; Obesity - complications; Obesity - drug therapy; Obesity - metabolism; Oxidative stress; Parkin protein; Phagosomes; Pharmacology/Toxicology; Protein Kinases - metabolism; PTEN-induced putative kinase; Ubiquitin-Protein Ligases - metabolism; Vaccine
• ISSN: 1671-4083; 1745-7254
• DOI: 10.1038/s41401-022-00919-1

Metabolic cardiomyopathy (MC) is characterized by intracellular lipid accumulation and utilizing fatty acids as a foremost energy source, thereby leading to excess oxidative stress and mitochondrial dysfunction. There is no effective therapy available yet. In this study we investigated whether defective mitophagy contributed to MC and whether urolithin A (UA), a naturally occurring microflora-derived metabolite, could protect against MC in experimental obese mice. Mice were fed high fat diet for 20 weeks to establish a diet-induced obese model. We showed that mitochondrial autophagy or mitophagy was significantly downregulated in the heart of experimental obese mice. UA (50 mg·kg −1 ·d −1 , for 4 weeks) markedly activated mitophagy and ameliorated MC in obese mice by gavage. In PA-challenged H9C2 cardiomyocytes, UA (5 μM) significantly increased autophagosomes and decreased autolysosomes. Furthermore, UA administration rescued PINK1/Parkin-dependent mitophagy and relieved mitochondrial defects in the heart of obese mice, which led to improving cardiac diastolic function and ameliorating cardiac remodelling. In PA-challenged primarily isolated cardiomyocytes, both application of mitophagy inhibitor Mdivi-1 (15 μM) and silencing of mitophagy gene Parkin blunted the myocardial protective effect of UA. In summary, our data suggest that restoration of mitophagy with UA ameliorates symptoms of MC, which highlights a therapeutic potential of UA in the treatment of MC. UA, a naturally-occurring compound, protects against diastolic dysfunction and cardiac remodelling in the obese mice, without altering the blood glucose level. Mechanistically, UA activated PINK1/Parkin dependent mitophagy, by which the mitochondrial defects including reduced respiratory capacity, MMP collapse and mitochondrial oxidative stress were alleviated.